[{"id":"cd52","kind":"target","name":"CD52","route":"/targets/cd52/","commit":"0bdbdae6c6","date":"2026-09-09","author":"Jude Gomila","message":"Editing pass: every TL;DR and summary stands alone","file":"src/data/gap-fill.ts","type":"changed","fields":[{"field":"tldr","before":"\"A small protein on nearly all lymphocytes, the target of alemtuzumab, a profoundly immunosuppressive antibody once used in CLL and now mostly in transplant conditioning, T-cell leukaemia and multiple sclerosis.\"","after":"\"CD52 is a small protein on nearly all lymphocytes and the target of alemtuzumab, a profoundly immunosuppressive antibody once used in CLL and now mostly in transplant conditioning, T-cell leukaemia and multiple scler..."}]},{"id":"cd52","kind":"target","name":"CD52","route":"/targets/cd52/","commit":"71e4eef6e1","date":"2026-09-08","author":"Jude Gomila","message":"Gap audit and gap-fill data: 33 cancers, 87 products, 20 targets, 25 technologies, 12 terms, 18 collections","file":"src/data/gap-fill.ts","type":"added","fields":[{"field":"id"},{"field":"name"},{"field":"symbol"},{"field":"targetClass"},{"field":"wikipedia"},{"field":"tldr"},{"field":"summary"},{"field":"biology"},{"field":"whereFound"},{"field":"cancers"},{"field":"technologies"},{"field":"terms"},{"field":"companies"},{"field":"links"},{"field":"tags"}]}]